Babic A, Rosenthal MH, Sundaresan TK, et al. Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer. Nature communications. 2023;14(1):4317. doi:10.1038/s41467-023-40024-3
Publications
Kanai M. Leveraging fine-scale population structures for precision healthcare. Nature medicine. 2023;29(7):1611-1612. doi:10.1038/s41591-023-02423-3
Als TD, Kurki MI, Grove J, et al. Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses. Nature medicine. 2023;29(7):1832-1844. doi:10.1038/s41591-023-02352-1
Singh H, Keller RB, Kapner KS, et al. Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023. doi:10.1158/1078-0432.CCR-22-3930
Kim Y, Kim S, Kim HJ, et al. National trends in body mass index, overweight, and obesity among adults before and during the COVID-19 pandemic in 2009-2021: A representative longitudinal serial study in South Korea. Journal of medical virology. 2023;95(7):e28958. doi:10.1002/jmv.28958
Khurshid S, Al-Alusi MA, Churchill TW, Guseh S, Ellinor PT. Accelerometer-Derived "Weekend Warrior" Physical Activity and Incident Cardiovascular Disease. JAMA. 2023;330(3):247-252. doi:10.1001/jama.2023.10875
Haghighi A, Alvandi Z, Nilipour Y, et al. Nemaline myopathy: reclassification of previously reported variants according to ACMG guidelines, and report of novel genetic variants. European journal of human genetics : EJHG. 2023. doi:10.1038/s41431-023-01378-w
Hoetker MS, Yagi M, Di Stefano B, et al. H3K36 methylation maintains cell identity by regulating opposing lineage programmes. Nature cell biology. 2023. doi:10.1038/s41556-023-01191-z
Chagas PS, Veronez LC, de Sousa GR, et al. Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells. Human cell. 2023. doi:10.1007/s13577-023-00954-y
Iesato A, Li S, Sadow PM, et al. The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment. Thyroid : official journal of the American Thyroid Association. 2023;33(7):835-848. doi:10.1089/thy.2022.0597